1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
58,51,200 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 85.99 | 53.27 | 46.59 | 47.47 |
| Total Income | 45.07 | 38.55 | 35.79 | 30.96 |
| Profit After Tax | 12.57 | 10.04 | 5.76 | 4.28 |
| EBITDA | 22.34 | 20.97 | 15.53 | 14.67 |
| NET Worth | 45.17 | 32.60 | 22.55 | 16.53 |
| Reserves and Surplus | 43.88 | 31.31 | 21.27 | 15.27 |
| Total Borrowing | 11.03 | 10.81 | 11.96 | 21.39 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Modern Diagnostic & Research Centre Ltd. | SME | ₹36.89 Cr | ₹90 | 11.04 | ₹94.99 | +5.54% | ₹52.00 (+1.96%) |
| Invicta Diagnostic Ltd. | SME | ₹28.12 Cr | ₹85 | 14.51 | ₹96.70 | +13.76% | ₹63.75 (-4.85%) |
| Star Imaging & Path Lab Ltd. | SME | ₹69.47 Cr | ₹142 | 12.01 | ₹135.95 | -4.26% | ₹87.30 (-3.78%) |
| Gaudium IVF & Women Health Ltd. | Mainboard | ₹165.00 Cr | ₹79 | 25.36 | ₹80.26 | +1.59% | ₹151.90 (-1.97%) |
| Nephrocare Health Services Ltd. | Mainboard | ₹871.05 Cr | ₹460 | 63.52 | ₹471.25 | +2.45% | ₹673.10 (-0.68%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres | 45.15 |
| 2 | General corporate purposes and unidentified inorganic acquisition | |
| Total | 45.15 |
About Pramodini Medicare IPO
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location. The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of December 31, 2025, the company operated 15 diagnostic centres across six states—
Contact Details
Pramodini Medicare Ltd. AddressD. No: - 29-4-54K, CSI Complex,Prakasam Road,SuryaraopetVijayawada, Andhra Pradesh, 520002+91 9985782727investors@pramodinidiagnostics.comVisit Website